Month: October 2020

With the Las Vegas Strip continuing to rebound and MGM (NYSE:MGM) receiving a roughly $1 billion investment from IAC (NASDAQ:IAC), the outlook of MGM stock has improved. Source: Michael Neil Thomas / Shutterstock.com Additionally, following the widespread introduction of a successful vaccine for the novel coronavirus, MGM is set benefit from a huge amount of
0 Comments
The global markets are really just one big interconnected web. We frequently see the prices of commodities and futures impact the movements of currencies, and vice versa. The same is true with the relationship between currencies and bond spread (the difference between countries’ interest rates): the price of currencies can impact the monetary policy decisions
0 Comments
Morgan Stanley CEO James Gorman has just completed a pivot that began more than a decade ago. With the announcement Thursday that Morgan Stanley is acquiring investment manager Eaton Vance for $7 billion, Gorman is adding heft and scale to the smallest of the New York-based bank’s three main businesses: the manufacturer of mutual funds
0 Comments
Jen-Hsun Huang, president and chief executive officer of Nvidia Corp., speaks during the company’s event at Mobile World Congress Americas in Los Angeles on Oct. 21, 2019. Patrick T. Fallon | Bloomberg | Getty Images Check out the companies making headlines after the bell Thursday: GenMark Diagnostics — GenMark shares popped more than 4% after
0 Comments
Never underestimate a good dividend. For that matter, never underestimate a quality company, brand and stock either. McDonald’s (NYSE:MCD) fits all of these criteria. That’s why it’s no surprise that McDonald’s stock is hitting new all-time highs. Source: ATIKAN PORNCHAIPRASIT / Shutterstock.com Even better, though, is that the thesis behind owning the stock doesn’t depend
0 Comments
CNBC’s Jim Cramer on Thursday advised investors to not buy shares of Regeneron Pharmaceuticals, simply because President Donald Trump touted the company’s potential coronavirus treatment.  Regeneron’s stock was higher by 2% on Thursday. In a video posted Wednesday, Trump claimed that Regeneron’s experimental antibody treatment for Covid-19, which the president received for his illness, was “a cure.” 
0 Comments
SINGAPORE — With uncertainty looming over the upcoming U.S. elections in November, JPMorgan Asset Management’s Patrik Schowitz says investors should look past the “noise” and focus on the medium term instead. “On a six month view, you know, we think the cyclical view matters much, much more than … the exact noise and shenanigans around the
0 Comments